NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle
NeuroScientific Biopharmaceuticals has secured key US backing for its Phase 2 stem cell Crohn’s trial, green-lighting a planned year-end start subject to regulatory, manufacturing and operational requirements.